Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Impedimed Limited ( (AU:IPD) ) just unveiled an update.
Impedimed Limited announced a proposed issue of securities, with a maximum of 12,491,870 warrants set to be issued. This strategic move aims to bolster the company’s financial position, potentially enhancing its operational capabilities and market competitiveness within the medical technology industry.
More about Impedimed Limited
Impedimed Limited operates within the medical technology industry, primarily focusing on the development of non-invasive medical devices for the assessment of fluid status and body composition. These devices serve various sectors within the healthcare market, including oncology, renal and heart failure management, and lymphedema diagnosis.
YTD Price Performance: -10.0%
Average Trading Volume: 33,136
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $64.61M
See more insights into IPD stock on TipRanks’ Stock Analysis page.
